BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19481178)

  • 1. Medullary serotonin defects and respiratory dysfunction in sudden infant death syndrome.
    Paterson DS; Hilaire G; Weese-Mayer DE
    Respir Physiol Neurobiol; 2009 Aug; 168(1-2):133-43. PubMed ID: 19481178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary Serotonin Neuron Abnormalities in an Australian Cohort of Sudden Infant Death Syndrome.
    Bright FM; Byard RW; Vink R; Paterson DS
    J Neuropathol Exp Neurol; 2017 Oct; 76(10):864-873. PubMed ID: 28922849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome.
    Paterson DS; Trachtenberg FL; Thompson EG; Belliveau RA; Beggs AH; Darnall R; Chadwick AE; Krous HF; Kinney HC
    JAMA; 2006 Nov; 296(17):2124-32. PubMed ID: 17077377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brainstem and serotonin in the sudden infant death syndrome.
    Kinney HC; Richerson GB; Dymecki SM; Darnall RA; Nattie EE
    Annu Rev Pathol; 2009; 4():517-50. PubMed ID: 19400695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome.
    Kinney HC; Randall LL; Sleeper LA; Willinger M; Belliveau RA; Zec N; Rava LA; Dominici L; Iyasu S; Randall B; Habbe D; Wilson H; Mandell F; McClain M; Welty TK
    J Neuropathol Exp Neurol; 2003 Nov; 62(11):1178-91. PubMed ID: 14656075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brainstem mechanisms underlying the sudden infant death syndrome: evidence from human pathologic studies.
    Kinney HC
    Dev Psychobiol; 2009 Apr; 51(3):223-33. PubMed ID: 19235901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Serotonin Brainstem Hypothesis for the Sudden Infant Death Syndrome.
    Kinney HC; Haynes RL
    J Neuropathol Exp Neurol; 2019 Sep; 78(9):765-779. PubMed ID: 31397480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The triple risk hypotheses in sudden infant death syndrome.
    Guntheroth WG; Spiers PS
    Pediatrics; 2002 Nov; 110(5):e64. PubMed ID: 12415070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome.
    Paterson DS
    Respir Physiol Neurobiol; 2013 Nov; 189(2):301-14. PubMed ID: 23851109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle autonomic and respiratory dysfunction in sudden infant death syndrome associated with serotonergic brainstem abnormalities: a case report.
    Kinney HC; Myers MM; Belliveau RA; Randall LL; Trachtenberg FL; Fingers ST; Youngman M; Habbe D; Fifer WP
    J Neuropathol Exp Neurol; 2005 Aug; 64(8):689-94. PubMed ID: 16106217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden infant death syndrome and serotonin: animal models.
    Nattie E
    Bioessays; 2009 Feb; 31(2):130-3. PubMed ID: 19204984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex.
    Bright FM; Vink R; Byard RW; Duncan JR; Krous HF; Paterson DS
    PLoS One; 2017; 12(9):e0184958. PubMed ID: 28931039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of substance P in brainstem homeostatic control in the pathogenesis of sudden infant death syndrome (SIDS).
    Bright FM; Vink R; Byard RW
    Neuropeptides; 2018 Aug; 70():1-8. PubMed ID: 29908886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullary serotonergic network deficiency in the sudden infant death syndrome: review of a 15-year study of a single dataset.
    Kinney HC; Filiano JJ; White WF
    J Neuropathol Exp Neurol; 2001 Mar; 60(3):228-47. PubMed ID: 11245208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased GABAA receptor binding in the medullary serotonergic system in the sudden infant death syndrome.
    Broadbelt KG; Paterson DS; Belliveau RA; Trachtenberg FL; Haas EA; Stanley C; Krous HF; Kinney HC
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):799-810. PubMed ID: 21865888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem serotonergic deficiency in sudden infant death syndrome.
    Duncan JR; Paterson DS; Hoffman JM; Mokler DJ; Borenstein NS; Belliveau RA; Krous HF; Haas EA; Stanley C; Nattie EE; Trachtenberg FL; Kinney HC
    JAMA; 2010 Feb; 303(5):430-7. PubMed ID: 20124538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome.
    Panigrahy A; Filiano J; Sleeper LA; Mandell F; Valdes-Dapena M; Krous HF; Rava LA; Foley E; White WF; Kinney HC
    J Neuropathol Exp Neurol; 2000 May; 59(5):377-84. PubMed ID: 10888367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum serotonin in sudden infant death syndrome.
    Haynes RL; Frelinger AL; Giles EK; Goldstein RD; Tran H; Kozakewich HP; Haas EA; Gerrits AJ; Mena OJ; Trachtenberg FL; Paterson DS; Berry GT; Adeli K; Kinney HC; Michelson AD
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7695-7700. PubMed ID: 28674018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of nicotinic receptors in the human medulla oblongata: inter-relationship with the serotonergic system.
    Duncan JR; Paterson DS; Kinney HC
    Auton Neurosci; 2008 Dec; 144(1-2):61-75. PubMed ID: 18986852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal nicotine-exposure alters fetal autonomic activity and medullary neurotransmitter receptors: implications for sudden infant death syndrome.
    Duncan JR; Garland M; Myers MM; Fifer WP; Yang M; Kinney HC; Stark RI
    J Appl Physiol (1985); 2009 Nov; 107(5):1579-90. PubMed ID: 19729586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.